Fonte: The Pharmacogenomics Journal. Unidade: FMRP
Assuntos: FARMACOLOGIA CLÍNICA, FARMACOLOGIA MÉDICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DESAI, M. et al. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6. The Pharmacogenomics Journal, v. 3, n. 2, p. 105-113, 2003Tradução . . Disponível em: https://doi.org/10.1038/sj.tpj.6500160. Acesso em: 02 nov. 2024.APA
Desai, M., Tanus-Santos, J. E., Li, L., Gorski, J. C., Arefayene, M., Liu, Y., et al. (2003). Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6. The Pharmacogenomics Journal, 3( 2), 105-113. doi:10.1038/sj.tpj.6500160NLM
Desai M, Tanus-Santos JE, Li L, Gorski JC, Arefayene M, Liu Y, Desta Z, Flockhart DA. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6 [Internet]. The Pharmacogenomics Journal. 2003 ; 3( 2): 105-113.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1038/sj.tpj.6500160Vancouver
Desai M, Tanus-Santos JE, Li L, Gorski JC, Arefayene M, Liu Y, Desta Z, Flockhart DA. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6 [Internet]. The Pharmacogenomics Journal. 2003 ; 3( 2): 105-113.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1038/sj.tpj.6500160
